Home
News Detail

US stock listing Solana treasury company Artelo Biosciences completes a $3 million share allocation

Source: ChainCatcher
According to ChainCatcher, Nasdaq-listed Solana treasury company Artelo Biosciences announced the issuance of 640,924 common shares to the public at a price of $4.4 per share, raising a total of about $3 million in funds. Artelo Biosciences is a clinical pharmaceutical company that has previously announced the formal launch of Solana's digital asset treasury strategy and invested part of its capital to purchase SOL tokens. It has held 45,883 SOLs so far.
Link copied to clipboard